Arabic Arabic English English French French German German
dark

CDER’s Office of Pharmaceutical Quality’s Use of Remote Interactive Evaluations

Throughout the COVID-19 public health emergency, CDER’s Office of Pharmaceutical Quality has been using all tools at our disposal to continue evaluating facilities to assure drug quality. One of these tools is remote interactive evaluation using livestreamed video of operations and remote, live interactions with operators. https://www.fda.gov/news-events/press-announcements/fda-provides-guidance-remote-interactive-evaluations-oversight-drug-facilities-during-covid-19

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

CDER’s Office of Compliance’s Use of Remote Interactive Evaluation

Next Post

Al-Jouf: 56,000+ Beneficiaries of «Tetamman» Clinics to Date

Related Posts
Total
0
Share